| Primary |
| Diffuse Large B-cell Lymphoma |
13.5% |
| Hodgkin's Disease |
7.8% |
| Adult T-cell Lymphoma/leukaemia |
7.3% |
| Acute Lymphocytic Leukaemia |
7.2% |
| Multiple Myeloma |
7.0% |
| Prophylaxis |
6.9% |
| Product Used For Unknown Indication |
6.8% |
| Non-hodgkin's Lymphoma |
6.5% |
| B-cell Lymphoma |
5.6% |
| Breast Cancer |
5.6% |
| Mantle Cell Lymphoma |
4.7% |
| Ovarian Cancer |
3.8% |
| Burkitt's Lymphoma |
3.4% |
| Drug Exposure During Pregnancy |
2.6% |
| Chronic Lymphocytic Leukaemia |
2.3% |
| Neoplasm Malignant |
2.1% |
| Breast Cancer Metastatic |
2.0% |
| Lymphoma |
1.8% |
| Ovarian Cancer Recurrent |
1.7% |
| Nausea |
1.6% |
|
| Off Label Use |
17.0% |
| Vomiting |
13.0% |
| Toxicity To Various Agents |
7.4% |
| Neutropenia |
6.5% |
| Interstitial Lung Disease |
5.6% |
| Thrombocytopenia |
5.2% |
| Pneumonia |
4.6% |
| Sepsis |
4.3% |
| Death |
3.7% |
| Neuropathy Peripheral |
3.7% |
| Myelodysplastic Syndrome |
3.4% |
| Pneumocystis Jiroveci Pneumonia |
3.4% |
| Hypertension |
3.1% |
| Ovarian Cancer |
3.1% |
| Pyrexia |
3.1% |
| Myocardial Infarction |
2.8% |
| White Blood Cell Count Decreased |
2.8% |
| Febrile Neutropenia |
2.5% |
| Pulmonary Toxicity |
2.5% |
| Stomatitis |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
11.5% |
| Prophylaxis |
10.6% |
| Adult T-cell Lymphoma/leukaemia |
10.2% |
| Diffuse Large B-cell Lymphoma |
9.4% |
| B-cell Lymphoma |
7.7% |
| Breast Cancer |
6.3% |
| Non-hodgkin's Lymphoma |
4.8% |
| Hodgkin's Disease |
4.2% |
| Ewing's Sarcoma |
4.0% |
| Multiple Myeloma |
3.8% |
| Bone Sarcoma |
3.7% |
| Mantle Cell Lymphoma |
3.4% |
| T-cell Lymphoma |
3.1% |
| Acute Lymphocytic Leukaemia |
3.1% |
| Drug Use For Unknown Indication |
2.7% |
| Ovarian Cancer |
2.5% |
| Foetal Exposure During Pregnancy |
2.4% |
| Lymphoma |
2.3% |
| Premedication |
2.3% |
| Malignant Lymphoid Neoplasm |
2.1% |
|
| White Blood Cell Count Decreased |
16.1% |
| Vomiting |
12.0% |
| Neutropenia |
7.5% |
| Off Label Use |
6.8% |
| Pyrexia |
6.6% |
| Febrile Neutropenia |
6.1% |
| Sepsis |
5.0% |
| Thrombocytopenia |
4.9% |
| Interstitial Lung Disease |
4.4% |
| Pneumonia |
3.9% |
| Stomatitis |
3.5% |
| Tachycardia |
3.3% |
| Death |
3.1% |
| Infection |
3.0% |
| Intestinal Obstruction |
2.7% |
| Neutrophil Count Decreased |
2.6% |
| Weight Decreased |
2.4% |
| Myelodysplastic Syndrome |
2.2% |
| Pancytopenia |
2.1% |
| Septic Shock |
2.0% |
|
| Concomitant |
| Chemotherapy |
19.6% |
| Non-hodgkin's Lymphoma |
11.0% |
| Diffuse Large B-cell Lymphoma |
10.0% |
| Lymphoma |
7.6% |
| Product Used For Unknown Indication |
7.1% |
| B-cell Lymphoma |
5.2% |
| Multiple Myeloma |
4.8% |
| Hiv Infection |
4.6% |
| Prophylaxis Of Nausea And Vomiting |
4.1% |
| Acute Lymphocytic Leukaemia |
3.9% |
| Neoplasm Malignant |
3.9% |
| Breast Cancer |
3.5% |
| Prophylaxis |
3.1% |
| Stem Cell Transplant |
2.6% |
| Non-hodgkin's Lymphoma Unspecified Histology Aggressive |
2.1% |
| Hypertension |
1.8% |
| T-cell Type Acute Leukaemia |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Cord Blood Transplant Therapy |
1.2% |
| Kaposi's Sarcoma |
1.1% |
|
| Febrile Neutropenia |
20.8% |
| Vomiting |
14.7% |
| Death |
9.3% |
| Pyrexia |
6.7% |
| Thrombocytopenia |
5.4% |
| Neutropenia |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
| Sepsis |
3.5% |
| Drug Ineffective |
3.2% |
| Pneumonia |
2.9% |
| Weight Decreased |
2.9% |
| Depressive Symptom |
2.6% |
| Dyspnoea |
2.6% |
| Pleural Effusion |
2.6% |
| Pneumonitis |
2.6% |
| White Blood Cell Count Increased |
2.6% |
| Hepatitis B |
2.2% |
| Therapeutic Response Decreased |
2.2% |
| Hallucination |
1.9% |
| Leukocytosis |
1.9% |
|
